Patents by Inventor Kris KAYENS

Kris KAYENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRANASAL ADMINISTRATION OF ESKETAMINE
    Publication number: 20230121313
    Abstract: The present invention is directed to pharmaceutical products, and to methods for the treatment of depression (e.g., major depressive disorder) and other diseases or disorders for which esketamine has a therapeutic benefit. In some embodiments, the methods are useful for the treatment of treatment-refractory or treatment-resistant depression or suicidal ideation. Methods of intranasal administration and devices for intranasal administration are also disclosed.
    Type: Application
    Filed: August 17, 2022
    Publication date: April 20, 2023
    Inventors: M. Ilias JIMIDAR, Jingli WANG, Caroline AERTS, Katrien VERBRUGGEN, Saartje THEUNIS, Jaskaran SINGH, Kris KAYENS, Peter ZANNIKOS, Hong YAN
  • ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND STORAGE
    Publication number: 20230058618
    Abstract: The disclosure is directed to pharmaceutical compositions comprising esketamine or a pharmaceutically acceptable salt thereof and an oxidative degradant. In certain aspects, the oxidative degradant is 6-(2-chlorophenyl)-6-oxohexanoic acid or a pharmaceutically acceptable salt thereof. Methods for limiting the formation of oxidative degradants in a pharmaceutical composition comprising esketamine or a pharmaceutically acceptable salt thereof are also disclosed.
    Type: Application
    Filed: December 14, 2020
    Publication date: February 23, 2023
    Inventors: Caroline Anne AERTS, Kris KAYENS, Koen Maria SCHRIJNEMAKERS, Mohamedilias JIMIDAR
  • INTRANASAL ADMINISTRATION OF ESKETAMINE
    Publication number: 20220339123
    Abstract: The present invention is directed to pharmaceutical products, and to methods for the treatment of depression (e.g., major depressive disorder) and other diseases or disorders for which esketamine has a therapeutic benefit. In some embodiments, the methods are useful for the treatment of treatment-refractory or treatment-resistant depression or suicidal ideation. Methods of intranasal administration and devices for intranasal administration are also disclosed.
    Type: Application
    Filed: March 4, 2020
    Publication date: October 27, 2022
    Inventors: M. Ilias JIMIDAR, Jingli WANG, Caroline AERTS, Katrien VERBRUGGEN, Saartje THEUNIS, Jaskaran SINGH, Kris KAYENS, Peter ZANNIKOS, Hong YAN